Qiagen Leads Strong Week for BCW Index | GenomeWeb

Qiagen's shares rose 8 percent for the five-day trading period ended Tuesday, leading the 13 firms that posted gains in the BCW Index. Qiagen reported a 9-percent increase in fourth-quarter revenues on Monday after the close of the market. Its shares gained 5.4 percent in the first full day of trading after the results were released. Only three firms posted declines in their stock for the tracking period, led by Invitrogen, which fell 1.3 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.